In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Mahtab Ahmed, MD, FOMA, Dipl. ABOM about a recent article on the safety and effectiveness of longer-term Phentermine use. Topics covered include risks and benefits of prescribing Phentermine longer than 12 weeks, the impact of study results only including low cardiovascular disease risk patients and being a retrospective study, and the role of local regulations in prescribing.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive review of obesity medicine that can be found at obesitymedicine.org. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org.
Episode Guests
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Mahtab Ahmed, MD, FOMA, Dipl. ABOM
Resources Mentioned
Leading cardiovascular researcher, D.r Carl "Chip" Lavie, has made many contributions to understanding and improving cardiovascular health including identifying the obesity paradox. Patients with...
In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1...
In this episode, obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Robert Kushner, highlighted speaker from the Overcoming Obesity...